InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.430
-0.030 (-2.05%)
At close: Aug 24, 2026, 4:00 PM EDT
1.450
+0.020 (1.40%)
After-hours: Aug 24, 2026, 7:31 PM EDT
InMed Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 5.16 | 11.08 | 6.57 | 8.91 | 6.18 | 7.36 |
Short-Term Investments | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 |
Cash & Short-Term Investments | 5.2 | 11.12 | 6.61 | 8.96 | 6.22 | 7.41 |
Cash Growth | 10.17% | 68.10% | -26.15% | 43.96% | -16.03% | 26.70% |
Accounts Receivable | - | 0.47 | 0.35 | 0.26 | 0.09 | - |
Other Receivables | - | - | - | - | - | 0.01 |
Receivables | - | 0.47 | 0.35 | 0.26 | 0.09 | 0.01 |
Inventory | - | 0.96 | 1.24 | 1.62 | 2.49 | - |
Prepaid Expenses | 0.62 | 0.32 | 0.48 | 0.5 | 0.8 | 0.84 |
Other Current Assets | 1.07 | - | - | - | - | 0.11 |
Total Current Assets | 6.89 | 12.87 | 8.69 | 11.33 | 9.6 | 8.38 |
Property, Plant & Equipment | 0.64 | 0.99 | 1.25 | 0.72 | 0.9 | 0.33 |
Other Intangible Assets | 1.5 | 1.62 | 1.78 | 1.95 | 2.11 | 1.06 |
Other Long-Term Assets | 0.1 | 0.1 | 0.1 | 0.1 | 0.18 | 0.01 |
Total Assets | 9.13 | 15.58 | 11.82 | 14.11 | 12.79 | 9.78 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 0.23 | 0.37 | 0.63 | 0.54 | 1.17 | 0.78 |
Accrued Expenses | 0.79 | 1.03 | 0.99 | 1.06 | 1.25 | 1.36 |
Current Portion of Leases | 0.39 | 0.44 | 0.32 | 0.38 | 0.4 | 0.08 |
Other Current Liabilities | 0.81 | 0 | 0.04 | 0.02 | 0.5 | - |
Total Current Liabilities | 2.21 | 1.84 | 1.97 | 2 | 3.32 | 2.22 |
Long-Term Leases | 0.03 | 0.31 | 0.64 | 0.02 | 0.39 | 0.19 |
Total Liabilities | 2.24 | 2.15 | 2.62 | 2.02 | 3.71 | 2.4 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 92.58 | 91.22 | 82.78 | 77.62 | 70.72 | 60.59 |
Additional Paid-In Capital | 38.14 | 39.32 | 35.37 | 35.74 | 31.68 | 21.51 |
Retained Earnings | -123.96 | -117.24 | -109.08 | -101.4 | -93.45 | -74.85 |
Comprehensive Income & Other | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
Shareholders' Equity | 6.89 | 13.43 | 9.21 | 12.09 | 9.08 | 7.38 |
Total Liabilities & Equity | 9.13 | 15.58 | 11.82 | 14.11 | 12.79 | 9.78 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 0.42 | 0.74 | 0.96 | 0.39 | 0.79 | 0.27 |
Net Cash (Debt) | 4.78 | 10.38 | 5.65 | 8.57 | 5.43 | 7.14 |
Net Cash Growth | 23.47% | 83.62% | -34.01% | 57.80% | -23.98% | 29.08% |
Net Cash Per Share | 1.42 | 10.63 | 14.83 | 69.96 | 193.57 | 531.24 |
Filing Date Shares Outstanding | 3.31 | 2.38 | 0.67 | 0.17 | 0.05 | 0.02 |
Total Common Shares Outstanding | 3.31 | 2 | 0.45 | 0.17 | 0.03 | 0.02 |
Working Capital | 4.68 | 11.03 | 6.72 | 9.33 | 6.28 | 6.16 |
Book Value Per Share | 2.08 | 6.71 | 20.64 | 72.65 | 279.06 | 458.14 |
Tangible Book Value | 5.39 | 11.81 | 7.42 | 10.14 | 6.97 | 6.31 |
Tangible Book Value Per Share | 1.63 | 5.90 | 16.65 | 60.95 | 214.23 | 392.20 |
Machinery | - | 0.43 | 0.47 | 0.48 | 0.25 | 0.07 |
Leasehold Improvements | - | - | - | - | - | 0.04 |